Evidence map›Paper›PMID 35330768›Full record

ArticleFrontiers in microbiology2022

Implantation of

Zuzana Chromiková, Romana Kalianková Chovanová, Dragana Tamindžija, Barbora Bártová, Dragan Radnović, Rizlan Bernier-Latmani, Imrich Barák

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Cr(VI) removal performance from wastewater byFrontiers in microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Zuzana ChromikováDepartment of Microbial Genetics, Institute of Molecular Biology, Slovak Academy of Sciences, Bratislava, Slovakia.
Romana Kalianková ChovanováDepartment of Microbial Genetics, Institute of Molecular Biology, Slovak Academy of Sciences, Bratislava, Slovakia.
Dragana TamindžijaDepartment of Chemistry, Faculty of Sciences, Biochemistry and Environmental Protection, Novi Sad, Serbia.
Barbora BártováEnvironmental Microbiology Laboratory, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Dragan RadnovićDepartment of Biology and Ecology, Faculty of Sciences, University of Novi Sad, Novi Sad, Serbia.
Rizlan Bernier-LatmaniEnvironmental Microbiology Laboratory, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Imrich BarákDepartment of Microbial Genetics, Institute of Molecular Biology, Slovak Academy of Sciences, Bratislava, Slovakia.
Institute of Molecular Biology of the Slovak Academy of Sciences · SKÉcole Polytechnique Fédérale de Lausanne · CHUniversity of Novi Sad · RS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chromium of anthropogenic origin contaminates the environment worldwide. The toxicity of chromium, a group I human carcinogen, is greatest when it is in a hexavalent oxidation state, Cr(VI). Cr(VI) is actively transported into the cell, triggering oxidative damage intracellularly. Due to the abundance of unspecific intracellular reductants, any microbial species is capable of bio-transformation of toxic Cr(VI) to innocuous Cr(III), however, this process is often lethal. Only some bacterial species are capable of sustaining the vegetative growth in the presence of a high concentration of Cr(VI) and thus operate as self-sustainable bioremediation agents. One of the successful microbial Cr(VI) detoxification strategies is the activation of chromate efflux pumps. This work describes transplantation of the chromate efflux pump from the potentially pathogenic but highly Cr resistant

Indexed as

bioremediationB. pseudomycoidesB. subtilischromate efflux pumpchromate tolerance

Identifiers

PMID35330768
PMCPMC8940164
OpenAlexW4220697370

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.